Published March 28, 2015 | Version v1
Journal article

Effects of Radiotherapy in the treatment of multiple myeloma: a retrospective analysis of a Single Institution

  • 1. Department of Radiation Oncology, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, Moorenstraße 5, 40225 Düsseldorf (Germany)
  • 2. Department of Radiation Oncology, Faculty of Medicine, University of Munich (LMU), Munich (Germany)
  • 3. Department of Hematology Oncology and Clinical Immunology, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, Dusseldorf (Germany)
  • 4. Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, Dusseldorf (Germany)
  • 5. Department of Dermatology, Faculty of Medicine, Heinrich-Heine-University Düsseldorf, Dusseldorf (Germany)
  • 6. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (United States)
  • 7. Faculty of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas (United States)
  • 8. Department of General, Medical Faculty, Visceral, and Thoracic Surgery, Asklepios Harz Hospitals, Goslar (Germany)

Description

Palliative irradiation of osteolytic lesions is a considerable component in the treatment for patients with multiple myeloma. In this study, we analyzed the efficacy of irradiation in these patients. We retrospectively analyzed 153 patients with multiple myeloma who were admitted to our department between 1989 and 2013. According to the staging system of Durie & Salmon 116 patients were classified as stage III. 107/153 patients were treated with radiotherapy of at least one and up to 6 bony lesions at different times. In order to evaluate the effect of local radiotherapy on pain relief and bone recalcification a uni- and multivariate analysis was performed using a binary logistic regression model to correct for multiple measurements. Complete information on dose, fractionation and volume of radiotherapy was available from 81 patients treated in 136 target volumes for pain relief, and from 69 patients treated in 108 target volumes for recalcification. Total radiation doses varied between 8 Gy to 50 Gy (median dose 25 Gy in 2.5 Gy fractions, 5 times a week). Radiotherapy resulted in complete local pain relief in 31% and partial local pain relief in 54% of the patients. In the univariate analysis, higher total radiation doses (p = 0.023) and higher age (p = 0.014) at the time of radiotherapy were significantly associated with a higher likelihood of pain relief, whereas no significant association was detected for concurrent systemic treatment, type and stage of myeloma and location of bone lesions. The same variables were independent predictors for pain relief in the multivariate analysis. Recalcification was observed in 48% of irradiated bone lesions. In the uni- and multivariate analysis higher radiation doses were significantly associated (p = 0.048) with an increased likelihood of recalcification. Side effects of radiotherapy were generally mild. Higher total biological radiation doses were associated with better pain relief and recalcification in this retrospective evaluation of multiple myeloma patients. In addition, in the elderly the therapeutic measures appear to develop a better analgesic effect

Availability note (English)

Available from http://dx.doi.org/10.1186/s13014-015-0374-z; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391087

Additional details

Publishing Information

Journal Title
Radiation Oncology (Online)
Journal Volume
10
Journal Page Range
vp.
ISSN
1748-717X

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47069953
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
FRACTIONATED IRRADIATION; GY RANGE 01-10; GY RANGE 10-100; MULTIVARIATE ANALYSIS; PAIN; PATIENTS; RADIATION DOSES; RADIOTHERAPY; SIDE EFFECTS; SKELETON
Descriptors DEC
ABSORBED DOSE RANGE; BODY; DOSES; GY RANGE; IRRADIATION; MATHEMATICS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIATION DOSE RANGES; RADIOLOGY; STATISTICS; SYMPTOMS; THERAPY

Optional Information

Copyright
Copyright (c) Matuschek et al.
Notes
PMCID: PMC4391087; PMID: 25889851; PUBLISHER-ID: 374; OAI: oai:pubmedcentral.nih.gov:4391087; licensee BioMed Central. 2015